SG11201604237PA - Novel compound for treatment of severe hypoglycemia - Google Patents

Novel compound for treatment of severe hypoglycemia

Info

Publication number: SG11201604237PA
Authority: SG; Singapore
Prior art keywords: treatment; novel compound; severe hypoglycemia; hypoglycemia; severe
Prior art date: 2013-12-18

Application number

SG11201604237PA

Inventor

Jorge Alsina-Fernandez

Robert Chadwick Cummins

Lili Guo

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-12-18

Filing date

2014-12-11

Publication date

2016-07-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52273565&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201604237P(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-12-11 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2016-07-28 Publication of SG11201604237PA publication Critical patent/SG11201604237PA/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

SG11201604237PA 2013-12-18 2014-12-11 Novel compound for treatment of severe hypoglycemia SG11201604237PA (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201361917716P	2013-12-18	2013-12-18
PCT/US2014/069644 WO2015094876A1 (en)	2013-12-18	2014-12-11	Novel compound for treatment of severe hypoglycemia

Publications (1)

Publication Number	Publication Date
SG11201604237PA true SG11201604237PA (en)	2016-07-28

Family

ID=52273565

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG11201604237PA SG11201604237PA (en)	2013-12-18	2014-12-11	Novel compound for treatment of severe hypoglycemia

Country Status (22)

Country	Link
US (1)	US20160311882A1 (en)
EP (1)	EP3083667A1 (en)
KR (1)	KR20160075826A (en)
CN (1)	CN105829340A (en)
AP (1)	AP2016009267A0 (en)
AR (1)	AR098615A1 (en)
AU (1)	AU2014366425B2 (en)
BR (1)	BR112016010635A2 (en)
CA (1)	CA2930596A1 (en)
CR (1)	CR20160227A (en)
DO (1)	DOP2016000142A (en)
EA (1)	EA201690966A1 (en)
HK (1)	HK1224305A1 (en)
IL (1)	IL245491A0 (en)
MA (1)	MA39110B1 (en)
MX (1)	MX2016007988A (en)
PE (1)	PE20160847A1 (en)
PH (1)	PH12016501183A1 (en)
SG (1)	SG11201604237PA (en)
TN (1)	TN2016000208A1 (en)
TW (1)	TW201609128A (en)
WO (1)	WO2015094876A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI622596B (en)	2015-10-26	2018-05-01	美國禮來大藥廠	Glucagon receptor agonists
WO2019140024A1 (en)	2018-01-12	2019-07-18	Eli Lilly And Company	Combination therapy
CA3128922A1 (en)	2019-02-05	2020-08-13	Eli Lilly And Company	Glucagon analog agonists and methods of using the same
MA55504A (en)	2019-04-01	2022-02-09	Novo Nordisk As	ANTIBODIES AGAINST LIRAGLUTIDE AND THEIR USE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2124974B1 (en)	2007-01-05	2017-03-15	Indiana University Research and Technology Corporation	Glucagon analogs exhibiting enhanced solubility in physiological ph buffers
WO2009099763A1 (en) *	2008-01-30	2009-08-13	Indiana University Research And Technology Corporation	Ester-based peptide prodrugs
CN102088989B (en) *	2008-06-17	2014-11-26	印第安纳大学研究及科技有限公司	Glucagon analogs exhibiting enhanced solubility and stability physiological pH buffers
EP2512503A4 (en) *	2009-12-18	2013-08-21	Univ Indiana Res & Tech Corp	Glucagon/glp-1 receptor co-agonists
CN103732618B (en) *	2011-06-10	2018-10-09	韩美科学株式会社	It is novel to secrete the sour pharmaceutical composition for treating obesity for adjusting peptide derivant and acid adjusting peptide derivant is secreted comprising this
EP2729493B1 (en) *	2011-07-04	2020-06-10	IP2IPO Innovations Limited	Novel compounds and their effects on feeding behaviour

2014
- 2014-12-04 AR ARP140104513A patent/AR098615A1/en unknown
- 2014-12-05 TW TW103142473A patent/TW201609128A/en unknown
- 2014-12-11 TN TN2016000208A patent/TN2016000208A1/en unknown
- 2014-12-11 AU AU2014366425A patent/AU2014366425B2/en not_active Ceased
- 2014-12-11 MA MA39110A patent/MA39110B1/en unknown
- 2014-12-11 SG SG11201604237PA patent/SG11201604237PA/en unknown
- 2014-12-11 CA CA2930596A patent/CA2930596A1/en not_active Abandoned
- 2014-12-11 KR KR1020167015880A patent/KR20160075826A/en not_active Application Discontinuation
- 2014-12-11 US US15/103,130 patent/US20160311882A1/en not_active Abandoned
- 2014-12-11 BR BR112016010635A patent/BR112016010635A2/en not_active IP Right Cessation
- 2014-12-11 AP AP2016009267A patent/AP2016009267A0/en unknown
- 2014-12-11 EP EP14821418.2A patent/EP3083667A1/en not_active Withdrawn
- 2014-12-11 PE PE2016000771A patent/PE20160847A1/en not_active Application Discontinuation
- 2014-12-11 MX MX2016007988A patent/MX2016007988A/en unknown
- 2014-12-11 EA EA201690966A patent/EA201690966A1/en unknown
- 2014-12-11 CN CN201480069406.3A patent/CN105829340A/en active Pending
- 2014-12-11 WO PCT/US2014/069644 patent/WO2015094876A1/en active Application Filing
2016
- 2016-05-05 IL IL245491A patent/IL245491A0/en unknown
- 2016-05-18 CR CR20160227A patent/CR20160227A/en unknown
- 2016-06-15 DO DO2016000142A patent/DOP2016000142A/en unknown
- 2016-06-17 PH PH12016501183A patent/PH12016501183A1/en unknown
- 2016-10-27 HK HK16112378.9A patent/HK1224305A1/en unknown

Also Published As

Publication number	Publication date
MA39110A1 (en)	2017-09-29
DOP2016000142A (en)	2016-07-15
TN2016000208A1 (en)	2017-10-06
BR112016010635A2 (en)	2017-12-05
MA39110B1 (en)	2018-04-30
CR20160227A (en)	2016-07-12
AU2014366425A1 (en)	2016-05-26
PE20160847A1 (en)	2016-09-10
AR098615A1 (en)	2016-06-01
AP2016009267A0 (en)	2016-06-30
MX2016007988A (en)	2016-09-09
KR20160075826A (en)	2016-06-29
TW201609128A (en)	2016-03-16
EP3083667A1 (en)	2016-10-26
US20160311882A1 (en)	2016-10-27
IL245491A0 (en)	2016-06-30
WO2015094876A1 (en)	2015-06-25
AU2014366425B2 (en)	2016-12-08
EA201690966A1 (en)	2016-12-30
CN105829340A (en)	2016-08-03
HK1224305A1 (en)	2017-08-18
PH12016501183A1 (en)	2016-07-25
CA2930596A1 (en)	2015-06-25

Publication	Publication Date	Title
IL241232A0 (en)	2015-11-30	Compounds for treatment of cancer
IL243976B (en)	2020-07-30	Kdm1a inhibitors for the treatment of disease
EP2968348A4 (en)	2016-11-09	Compounds for treatment of cancer
EP2968321A4 (en)	2016-11-09	Compounds for treatment of fibrosis diseases
HK1224324A1 (en)	2017-08-18	Treatment of coal
HK1219737A1 (en)	2017-04-13	Novel compounds for the treatment of cancer
HK1224305A1 (en)	2017-08-18	Novel compound for treatment of severe hypoglycemia
EP2903643A4 (en)	2016-06-15	Treatment of psychiatric conditions
HK1224304A1 (en)	2017-08-18	Novel compound for treatment of severe hypoglycemia
HK1224303A1 (en)	2017-08-18	Novel compound for treatment of severe hypoglycemia
EP2986294A4 (en)	2016-11-16	Compounds for treatment of pain
GB201607581D0 (en)	2016-06-15	Treatment of cancer
GB201308466D0 (en)	2013-06-19	Improved process for treatment of minewater
HRP20182110T1 (en)	2019-02-22	Composition of tiacumicin compounds
HK1232118A1 (en)	2018-01-05	Treatment of cancer
HK1204865A1 (en)	2015-12-11	Composition for elimination of troublesome varmints
EP2986295A4 (en)	2016-11-09	Compounds for treatment of pain
PL3016948T3 (en)	2017-10-31	2-acylaminothiazoles for the treatment of cancer
AP2015008905A0 (en)	2015-12-31	Novel compounds for the treatment of cancer
GB201321628D0 (en)	2014-01-22	Treatment of disease
GB201322347D0 (en)	2014-02-05	Treatment of cancer
GB201318742D0 (en)	2013-12-04	Treatment of cancer
GB201308529D0 (en)	2013-06-19	Treatment of cancer
GB201305020D0 (en)	2013-05-01	Treatment of cancer